Cash Flow from Financial Activities: The net amount of cash transactions used in funding activities.
Fulcrum Therapeutics, Inc. (FULC) had Cash Flow from Financial Activities of $0.04M for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
-- |
|
$-26.18M |
|
-- |
|
-- |
|
$29.31M |
|
$-29.31M |
|
$3.13M |
|
$-26.18M |
|
$-26.18M |
|
$-26.18M |
|
$-26.18M |
|
$-26.18M |
|
$-26.18M |
|
$-29.31M |
|
$-29.09M |
|
76.26M |
|
76.26M |
|
$-0.34 |
|
$-0.34 |
|
| Balance Sheet Financials | |
$322.85M |
|
-- |
|
$1.10M |
|
$323.95M |
|
$10.30M |
|
-- |
|
$2.96M |
|
$13.26M |
|
$310.70M |
|
$310.70M |
|
$310.70M |
|
76.28M |
|
| Cash Flow Statement Financials | |
$-34.79M |
|
$-114.43M |
|
|
Cash Flow from Financial Activities |
$0.04M |
$198.73M |
|
$49.56M |
|
$-149.18M |
|
$7.13M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
31.35 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-34.45M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-8.43% |
|
-8.43% |
|
-8.08% |
|
-8.43% |
|
$4.07 |
|
$-0.45 |
|
$-0.46 |
|